Papakonstantinou Stamatina

Papakonstantinou Stamatina Nephrologist

Education & Academic Qualifications

  • 23/09/1996: Graduate of Medical University of Sofia, Bulgaria
  • 23/12/2005: Awarded Nephrology specialty title after exams

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Hellenic Nephrology Society (ENE)

  • European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)

  • International Society of Nephrology (ISN)

 

Work Experience

  • Countryside service, Community Health Center of Siatista, General Hospital of Kozani, 1997 – 1999

  • Residency in Internal Medicine, General Hospital of Veroia, 1999 – 2001

  • Residency in Nephrology, General Hospital of Veroia, 2001- 2005

  • Residency in Renal Transplantation, Hippokration General Hospital of Thessaloniki, Organ Transplant Clinic, 2005

  • Nephrologist, Dialysis Unit, Hygeia Hospital Athens, 2005 – 2009

  • Nephrologist, Nephrology Institute Athens, 2009 – 2012

  • Nephrologist, Scientific partner/contributor, Hygeia Hospital Athens since 2012

 

Clinical & Research Interest

Clinical Interest:

  • Diagnostic approach and treatment of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)

  • Hemodialysis treatment versions (Chronic Dialysis, Acute Dialysis, Continuous Renal Replacement Therapy) 

  • Diagnosis and Treatment of primary and secondary renal diseases

  • Diagnosis and Treatment of Arterial Hypertension

  • Diabetic Nephropathy

  • Metabolic Workup of Renal Lithiasis

  • Geriatric Nephrology

Research Interest:

  • Complications of CKD

  • Renal Anemia

  • Renal Bone Disease, Secondary Hyperparathyroidism

  • Renal Nutrition

Researcher in Greek and International multicenter clinical trials:

  • NESP 20000259 phase IIIb

  • ΜΟ1-367

  • AURORA STUDY

 

Recent Publications

  • Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients, Nephrology, Volume 14 Issue 6, Pages 560 – 564, Published Online: 3 Mar 2009

  • Prevalence of the metabolic syndrome in hemodialysis, Int J Artif Organs 2007 Feb; 30 (2): 118-23

  • Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece, In Vivo January 1, 2009 vol. 23 no. 1, 177-181

  • Characteristics of uremic pruritus in hemodialysis patients: data from a single center, Kidney International (2008) 74, 962; doi:10.1038/ki.2008.359

  • Loss of hepatitis b immunity in hemodialysis patients acquired either naturally or after vaccination, Clinical Nephrology, Volume 68, No. 4/2007

  • Unit dosing of darbepoetin alfa for the treatment of anemia in patients with esrd being switched from recombinant human erythropoietin: results of a phase ΙΙΙb, 27-week, multicenter, open-label study in greek patients, Current Therapeutic Research, vol.66, no 3, May/June 2005

  • A rare case of peritonitis caused by flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis, Geriatric Nephrology and Urology, (2005) 37: 433-436

  • Δέκα χρόνια εμπειρίας στη συνεχή φορητή περιτοναϊκή κάθαρση (ΣΦΠΚ) σε ένα κέντρο δευτεροβάθμιας περίθαλψης, Ελληνική Νεφρολογία 2004; 16 (1): 76-82

  • Υποτροπιάζουσες και de novo σπειραματονεφρίτιδες στο νεφρικό μόσχευμα, Ελληνική Νεφρολογία 2004; 16 (2): 127-135

  • Η εφαρμογή των κατευθυντηρίων οδηγιών στην κλινική πράξη, Ελληνική νεφρολογία 2006; 18 (1): 27-33